Get started
CASSAVA SCIENCES, INCCASSAVA SCIENCES, INCCASSAVA SCIENCES, INC

CASSAVA SCIENCES, INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Forecast Seasonals

SAVA trade ideas

HOW TO: Find and Buy Super Performance Stocks Up Over 1,000%I always start these videos with the genuine intent of making them around 5 minutes as that's about the time it would take me to go through the process of finding, filtering and buying these shares, but I always think that "someone might find this functionality useful or interesting" so the videos end up longer than expected. Thank goodness TradingView not only makes it so easy to create and share them, but also has a 20 minute cut-off limit :) This video includes how to: 1. Find super performance stocks up over 1,000% 2. Filter out the less liquid stocks with low volume 3. Add them to a watch list 4. Sort them by which ones are already up in the pre-market 5. Go through them one by one looking for set ups I like the look of for whatever reason 6. Have a quick look at the news for the stock to see if there are any interesting headlines or red flags 7. Place an order for the stock and add a stop loss to protect my position This one video actually contains a HEAP of information so I hope you find something in the video that you might not have seen before. TradingView is truly a remarkable platform :)
NASDAQ:SAVAEducation
by zAngus
12
Cassava Sciences | In July we might see a big boom!Cassava Sciences is developing an Alzheimer drug, which not just slow the disease, but reverses it! In February they announced some incredible data for their 6-month open label study. That was the reason for the massive price increase. After that, the share price started declining due to some uncertainty. But a few weeks ago they announced to present the 9-month data set on a huge scientific conference in July. For me that's a very very positive signal! Just imagine - would you present a failure on such a big stage? Certainly NO! Personally I used this opportunity to buy more shares. The anticipation of the data release has already started but I am still adding below 60$. The CEO already spreaded some excitement about the data. He didn't want to "spill the beans yet", since Cassava is not allowed to publish the new study data before the conference. I am actually super bullish on this and can't wait to see the new data. My price target per share is > 400$ Disclaimer: This is no financial advice! Do your own due diligence before investing! I am just sharing my thoughts on this.
NASDAQ:SAVALong
by Silbert
3
Cassava | Bullish reversal - use your chance until JulyCassava Sciences is developing an Alzheimer drug, which not just slow the disease, but reverses it! In February they announced some incredible data for their 6-month open label study. That was the reason for the massive price increase. After that, the share price started declining due to some uncertainty. But last week they announced to present the 9-month data set on a huge scientific conference. For me that's a very very positive signal! Just imagine - would you present a failure on such a big stage? Certainly NO! Personally I used this opportunity to buy more shares.
NASDAQ:SAVALong
by Silbert
3
Companies Selling Stock Were Outperforming The Nasdaq By 40%ZeroHedge, Wed, 08/26/2020 - 10:05 "2020 has been a stunning year for countless reasons, and one of them as we previously reported is that following the covid pandemic there was an absolute avalanche of equity offerings, culminating with some $113 billion in stock sales in the second quarter as we showed before. "Yet while the staggering amount of follow-on offerings is not news, the performance of companies selling their stock is nothing short of shocking, because whereas in a normal world the association dilution with new equity sales would in theory result in depressed stock prices, the reality of the past few months has been anything but. First, a quick update on equity offerings as of late August. As Bloomberg notes today, a new milestone in secondary offerings shows the power of this year’s unique market in bringing together sellers and buyers. Issuers and their largest holders have now priced 783 secondary offerings on U.S. exchanges this year, with the total surpassing 2019’s full-year total of 780 on Monday. In terms of cash proceeds, the $169 billion raised in this year’s secondaries is already the most for a full calendar year since 2015. And unlike the surge in IPOs, which has been driven largely by special purposes acquisition companies, Bloomberg notes that these secondary offerings are being conducted in real businesses. Two main factors deserve the credit for this years-high in deal flow. On the sell side, companies found themselves scrambling to cover cash needs, while a pandemic spoiled expectations for revenue. On the buy side, traders kept coming back for more after recent deals shocking outperformed the broader market. And here is the punchline: stocks sold in 2020 secondary offerings closed on Tuesday 39% above their offering price on average. That’s outpacing the year’s 28% gain in the Nasdaq Composite Index, a 40% outperformance. There's more: the performance of July’s 98 secondaries, which closed Tuesday an average of 278% above their offering price, serves as a recent and major source of excitement for more paper in the market. Indeed, if investors are clamoring for public companies to sell their stock and raise cash, which company in its right mind would say no? As Bloomberg concludes, while the pace of deals is now slowing heading into a traditional vacation period for equity capital markets, bankers are optimistic that the final four months of 2020 continue to serve as fertile grounds for even more secondary offerings." "Companies raised more money through stock market listings in 2020 than in any year besides 2007", FT "Companies raised more money through stock market listings in 2020 than in any year besides 2007, as a rebound in equities valuations lured in businesses and blank-cheque acquisition vehicles rushed to list in the US. Businesses raised almost $300bn through flotations globally in 2020, including a record $159bn in the US, according to data provider Refinitiv. The boom included the public debuts of high-flying tech businesses such as DoorDash and Airbnb, as well as listings for groups that seek to buy others and fast-track them on to public markets."
NASDAQ:SAVA
by stocktradez6
4